Litcius/Paper detail

Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations

Kathleen F. Mittendorf, Tia L. Kauffman, Laura M. Amendola, Katherine Anderson, Barbara B. Biesecker, Michael O. Dorschner, Devan M. Duenas, Donna J. Eubanks, Heather Spencer Feigelson, Marian J. Gilmore, Jessica Ezzell Hunter, Galen Joseph, Stephanie A. Kraft, Sandra Soo‐Jin Lee, Michael C. Leo, Elizabeth Liles, Nangel M. Lindberg, Kristin R. Muessig, Sonia Okuyama, Kathryn M. Porter, Leslie Riddle, Bradley A. Rolf, Alan F. Rope, Jamilyn M. Zepp, Gail P. Jarvik, Benjamin S. Wilfond, Katrina A.B. Goddard

2021Contemporary Clinical Trials31 citationsDOIOpen Access PDF

Abstract

Advances in the application of genomic technologies in clinical care have the potential to increase existing healthcare disparities. Studies have consistently shown that only a fraction of eligible patients with a family history of cancer receive recommended cancer genetic counseling and subsequent genetic testing. Care delivery models using pre-test and post-test counseling are not scalable, which contributes to barriers in accessing genetics services. These barriers are even more pronounced for patients in historically underserved populations. We have designed a multimodal intervention to improve subsequent cancer surveillance, by improving the identification of patients at risk for familial cancer syndromes, reducing barriers to genetic counseling/testing, and increasing patient understanding of complex genetic results. We are evaluating this intervention in two large, integrated healthcare systems that serve diverse patient populations (NCT03426878). The primary outcome is the number of diagnostic (hereditary cancer syndrome) findings. We are examining the clinical and personal utility of streamlined pathways to genetic testing using electronic medical record data, surveys, and qualitative interviews. We will assess downstream care utilization of individuals receiving usual clinical care vs. genetic testing through the study. We will evaluate the impacts of a literacy-focused genetic counseling approach versus usual care genetic counseling on care utilization and participant understanding, satisfaction, and family communication. By recruiting participants belonging to historically underserved populations, this study is uniquely positioned to evaluate the potential of a novel genetics care delivery program to reduce care disparities.

Topics & Concepts

MedicineGenetic counselingGenetic testingIntervention (counseling)CancerHealth careFamily medicineMedical geneticsCancer preventionHealth literacyNursingGeneticsEconomicsBiologyEconomic growthGeneInternal medicineBRCA gene mutations in cancerGenomics and Rare DiseasesCancer Genomics and Diagnostics
Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations | Litcius